Darshan
FDA regulatory lawyer, futurist, inventor
Score (What’s this?)
Perlu Network score measures the extent of a member’s network on Perlu based on their connections, Packs, and Collab activity.
Pulse (What’s this?)
Perlu Pulse score measures how active a member is on Perlu, on a scale of 0 to 100.
#FDA regulatory lawyer who frequently speaks about the cross section of drugs, devices, technology, cannabis, health and innovation. Host of @GavelandPestle | Atty @kulkarnilawfirm | Visiting Prof @USciences. I have been quoted in many major publications like Forbes, Stat, and more and have written multiple textbooks on these topics and am the go to authority on issues relating to drugs, devices, cosmetics, nicotine and health.
- Moz DA 24
- Moz DA 14
- Moz DA N/A
In this episode, Darshan talks about the most useful degrees pharmacists can get after recieving their doctorate in pharmacy, and how these degrees can translate into new careers in the life sciences. Here are the top five degrees pharmacists can often get after their PharmD. Degree number one, I might be biased, but a Juris Doctorate degree. So we're talking about coronavirus, we're talking about COVID, MPH degrees, especially in the context of pharmacy become really useful because someone's got to talk and advise on what are the public health implications associated with pharmacy and whether you're going to use hydroxychloroquine or if there's something better out there, and what is the impact on population dynamics? The fifth degree that does pop up is actually someone who goes from getting a doctorate in pharmacy to getting a bachelor's in informatics.
Before this week's podcast, Is Off-Label Marketing by a Pharma Company a Bad Thing?, Darshan will introduce this episode with the recap for the week of Thursday, June 11th, 2020. " Off-label marketing becomes slightly problematic, because that would be a pharmaceutical company taking products that don't have enough evidence and promoting them for another use. That has slowly shifted over time, because it turns out that even those companies were doing it off of tons of evidence, and the FDA was going and finding those companies. Off-label marketing is bad, in my opinion, if there's not enough evidence to support the use that you are recommending.
Join FDA regulatory attorney Darshan Kulkarni as he discusses the 5 most important points to consider before starting a business in the life sciences. As awareness of the General Data Protection Regulation (GDPR) increases, companies are scrambling to protect customers' personal data. Before You Start Your Life Science Business Make sure to subscribe to our newsletter and be the first to know the news. Before You Start Your Life Science Business Be the first to receive the newest podcasts!
Join Darshan Kulkarni as he discusses the steps required to bring a drug to market. Join FDA regulatory attorney Darshan Kulkarni as he talks about... : An Interview with Kelly Willenberg Marketing events can be very valuable opportunities to network with peers in your industry. As more states pass cannabis supportive laws, companies often need to reevaluate how they approach cannabis use.